Trials Supporting FDA Approval of Breakthrough Drugs Examined
TUESDAY, July 17, 2018 -- Pivotal trials supporting U.S. Food and Drug Administration approvals granted Breakthrough Therapy designation often lack randomization, double-blinding, and control groups, according to a research letter published in the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Food and Drug Administration (FDA) | Pharmaceuticals